SHEPHERD Therapeutics


Khora Therapeutics is pioneering the next frontier in advanced precision medicine, aiming to revolutionize healthcare with innovative solutions.

Industries

biopharma
biotechnology
health-care
life-science
medical
therapeutics

Nr. of Employees

small (1-50)


Products

DELVE

A platform that uses whole genome and transcriptome data to identify personalized therapeutic options for cancer patients by analyzing the impact of over 509 drugs on the entire transcriptome.

Single Agents

Individual drugs matched to a tumor based on its response-resistance signature, indicating a high probability of therapeutic benefit.

Combo Agents

Drug combinations created from single agents that pass DELVE’s tests, including both known and novel combinations tailored to each patient and tumor.

Shepherd Report

A detailed report providing information on individual growth pathways in a patient's cancer sample and recommending single-drug and multi-drug therapies.

Population Identification

Identifies patient populations from over 160 cancer types using RNA markers to support clinical trial selection and patient stratification.

Toxicity Prediction

Predicts potential toxic side effects of therapeutics on healthy tissue by applying derived signatures to raw RNA data.

Expertise Areas

  • Precision medicine
  • Translational research
  • Therapeutic development

Key Technologies

  • Precision medicine platforms
  • Biomarker discovery methods
  • Personalized therapeutic development

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.